Elevated serum IL‐6 levels are also observed in patients with inflammatory bowel disease19, and IL‐6 levels generally correlate with tumor size, stage, and metastasis in colorectal cancer (CRC) patients20. This evidence concerns the gene IL6 and colorectal cancer.